Safe Lentiviral Vectors for Targeted Delivery of Multiple Therapeutic Molecules
Country:
US
Docket No:
436313-002437
Publication Number:
2021/0401868 11,617,760
Patent Expiry:
10/19/2029
Claims Scope:
Patent issued April 4, 2023.
System and composition to a self-inactivating transfer vector free of wPRE;
multiple gene units each operably linked to a regulatory sequence;
a mammalian insulator sequence.
